Announcements

14 May 2025
MDPI’s Journal Cluster of Microbiology


Microbiology is a dynamic and interdisciplinary field dedicated to understanding the biology of microorganisms and their critical roles in health, industry, and the environment. This discipline explores the vast diversity of microscopic life—including bacteria, viruses, fungi, protozoa, and algae—by investigating their structure, function, genetics, physiology, and ecology. Microbiology also delves into the complex interactions between microorganisms and their hosts, providing insights into processes such as disease, immunity, and nutrient cycling. By integrating knowledge from many disciplines, microbiology drives innovation across medicine, agriculture, industry, and environmental science. Its contributions to infectious disease control, antibiotic development, fermentation technology, biotechnology, and environmental remediation continue to address global challenges and deepen our understanding of the essential microbial world.

MDPI’s microbiology cluster has a mission to publish cutting-edge research, furthering our understanding of the microbial world. The cluster aims to accelerate development in the field to drive advancements in microbiology and its role in human health and medicine, the environment, industrial processes and technology. This cluster offers authors diverse publishing options, ensuring their research finds the most relevant and impactful audience within the diverse landscape of microbiology.

The six participating journals include the following:

  • Applied Microbiology (ISSN: 2673-8007) provides an advanced forum for studies related to the application of microorganisms, with a strong emphasis on biotechnology, environment, medicine, and food. Applied Microbiology is led by its Editor-in-Chief Prof. Dr. Ian Connerton (Division of Microbiology, Brewing and Biotechnology, University of Nottingham, UK);
  • Bacteria (ISSN: 2674-1334) covers all aspects of bacteriology and mainly publishes reviews, research papers, and communications, but other article types will also be considered. Bacteria is led by its Editor-in-Chief Prof. Dr. Bart C. Weimer (Department of Population Health and Reproduction, School of Veterinary Medicine, University of California, USA);
  • Journal of Fungi (JoF, ISSN: 2309-608X) provides an advanced forum for studies related to pathogenic fungi, fungal biology, and all other aspects of fungal research. Journal of Fungi is led by its Editor-in-Chief Prof. Dr. David S. Perlin (Hackensack Meridian Health Center for Discovery and Innovation, USA);
  • Microorganisms (ISSN: 2076-2607) focuses on cutting-edge research across the entire field of microbiology, involving all branches of microbiology. Microorganisms is led by Editor-in-Chief Dr. Nico Jehmlich (Department of Molecular Toxicology, UFZ-Helmholtz Centre for Environmental Research, Germany);
  • Microbiology Research (ISSN: 2036-7481) publishes theoretical and experimental research across all fundamental and applied microbiology fields, advancing One Health and Circular Health perspectives. Microbiology Research is led by Editor-in-Chief Prof. Dr. Beniamino T. Cenci-Goga (Department of Veterinary Medicine, University of Perugia, Italy);
  • Viruses (ISSN: 1999-4915) provides an advanced forum for studies of viruses. Our aim is to publish papers that are of significant impact to the virology community, and to help researchers present their cutting-edge findings and opinions in detail by receiving quick dissemination among their peers. Viruses is led by its Editor-in-Chief Dr. Eric O. Freed (HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, USA).

 Journals

Launch Year

Impact Factor (2023)

CiteScore

First Decision (median)

Acceptance to Publication (median)

APC

2021

-

-

14.3 days

3.4 days

CHF 1000

2022

-

-

27.4 days

4.3 days

CHF 1000

2015

4.2

6.7

17.7 days

2.7 days

CHF 2600

2013

4.1

7.4

11.7 days

2.7 days

CHF 2700

2010

2.1

1.9

15.4 days

2.7 days

CHF 1600

2009

3.8

7.3

17.1 days

2.7 days

CHF 2600

MDPI Mission and Values:
As a pioneer of academic open access publishing, MDPI has been serving the scientific community since 1996. Our aim is to foster scientific exchange in all forms across all disciplines. MDPI’s guidelines for disseminating open science are based on the following values and guiding principles:

  • Open Access: All of our content is published in open access and distributed under a Creative Commons License, providing free access to science and the latest research, allowing articles to be freely shared and content to be re-used with proper attribution;
  • Timeliness and Efficiency: Publishing the latest research through thorough editorial work, ensuring a first decision is provided to authors in under 32 days and papers are published within 7-10 days upon acceptance;
  • Simplicity: Offering user-friendly tools and services in one place to enhance the efficiency of our editorial process;
  • High-Quality Service: Supporting scholars and their work by providing a range of options such as journal publication at mdpi.com, early publication at preprints.org, and conferences on sciforum.net to make a positive impact on research;
  • Flexibility: Adapting and developing new tools and services to meet the changing needs of the research community, driven by feedback from authors, editors, and readers;
  • Rooted in Sustainability: Ensuring the long-term preservation of published papers and supporting the future of science through partnerships, sponsorships, and awards.

By adhering to these values and principles, MDPI remains committed to advancing scientific knowledge and promoting open science practices.

Selected Topics and Topical Collection:
News and Updates on Probiotics
Topic Editors: Dr. Alessandra Pino and Dr. Mutamed Ayyash
Manuscript submission deadline: 31 December 2025

Feature Papers in Bacteria
Collection Editor: Prof. Dr. Bart C. Weimer

Pathophysiology and Clinical Management of Fungal Infections
Topic Editors: Dr. Allan J. Guimarães and Dr. Marcos de Abreu Almeida
Manuscript submission deadline: 30 November 2025

Antimicrobial Agents and Nanomaterials—2nd Edition
Topic Editors: Prof. Dr. Vasco D. B. Bonifácio and Dr. Sandra Pinto
Manuscript submission deadline: 31 December 2026

Microbiota Diversity and Its Broader Biological Implications Across Human and Animal Health
Topic Editors: Dr. Giovanna Liguori, Dr. Luc van Nassauw and Dr. Anna Costagliola

Efficacy and Safety of Antiviral Therapy
Collection Editors: Prof. Dr. Giordano Madeddu, Dr. Andrea De Vito and Dr. Agnese Colpani

Selected Articles:
Salmonella: Role in Internal and External Environments and Potential as a Therapeutic Tool
by Patrick J. Naughton, Violetta R. Naughton and James S. G. Dooley
Appl. Microbiol. 2024, 4(4), 1515-1533; https://doi.org/10.3390/applmicrobiol4040104

Antimicrobial Resistance and Novel Alternative Approaches to Conventional Antibiotics
by Irene Berger and Zvi G. Loewy
Bacteria 2024, 3(3), 171-182; https://doi.org/10.3390/bacteria3030012

Molecular Diagnostics for Invasive Fungal Diseases: Current and Future Approaches
by David Pham, Varsha Sivalingam, Helen M. Tang, James M. Montgomery, Sharon C.-A. Chen and Catriona L. Halliday
J. Fungi 2024, 10(7), 447; https://doi.org/10.3390/jof10070447

The Potential Impact of Probiotics on Human Health: An Update on Their Health-Promoting Properties
by Nicoleta-Maricica Maftei, Cosmin Raducu Raileanu, Alexia Anastasia Balta, Lenuta Ambrose, Monica Boev, Denisa Batîr Marin and Elena Lacramioara Lisa
Microorganisms 2024, 12(2), 234; https://doi.org/10.3390/microorganisms12020234

Adenovirus-Mediated Expression of Dengue Virus 2 Envelope Ferritin Nanoparticles Induced Virus-Specific Immune Responses in BALB/c Mice
by M.S.B.W.T.M. Nipuna Sudaraka Tennakoon, Ji-Hoon Ryu, Yong-Sam Jung, Yingjuan Qian, and Hyun-Jin Shin
Microbiol. Res. 2024, 15(3), 1913-1923; https://doi.org/10.3390/microbiolres15030128

The Medicinal Phage—Regulatory Roadmap for Phage Therapy under EU Pharmaceutical Legislation
by Timo Faltus
Viruses 2024, 16(3), 443; https://doi.org/10.3390/v16030443

More News...
Back to TopTop